ERBB2 and breast carcinoma: In clinical practice, breast cancer is classified into different subtypes based on the expression of hormone receptors (HRs), including estrogen receptor (ER) and progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (Waks and Winer, 2019).